Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Assembly Biosciences Inc
ASMBCurrent price
17.05 USD
+0.2 USD (+1.19%)
Last closed
16.57 USD
Company
www.assemblybio.com
ISIN
US9228221019
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
106 478 504 USD
Yield for 12 month
+92.52 %
1Y
3Y
5Y
10Y
15Y
ASMB
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California. Address: Two Tower Place, South San Francisco, CA, United States, 94080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
35.5 USDP/E ratio
–Dividend Yield
–Current Year
+7 163 000 USD
Last Year
–
Current Quarter
+6 845 000 USD
Last Quarter
+8 533 000 USD
Current Year
+6 713 000 USD
Last Year
-498 000 USD
Current Quarter
+6 845 000 USD
Last Quarter
+8 501 000 USD
Key Figures ASMB
1 year
3 years
5 years
10 years
EBITDA
-50 267 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.72 %
PEG Ratio
–
Return On Equity TTM
-101.78 %
Wall Street Target Price
35.5 USD
Revenue TTM
21 481 000 USD
Book Value
7.5 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
-63 895 000 USD
Earnings per share
-8.69 USD
Diluted Eps TTM
-8.69 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-212.33 %
Dividend Analytics ASMB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ASMB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
12.02.2024
Dividend Date
–
Stock Valuation ASMB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.4145
Price Sales TTM
4.9569
Enterprise Value EBITDA
0.4244
Price Book MRQ
3.0701
Financials ASMB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ASMB
For 52 weeks
7.69 USD
19.93 USD
50 Day MA
16.71 USD
Shares Short Prior Month
17 790
200 Day MA
14.47 USD
Short Ratio
0.41
Shares Short
16 423
Short Percent
0.38 %
BeatStart